Existence Genetics Founder Brandon Colby, MD to Speak at 2nd Annual Consumer Genetics Conference
Author of Outsmart Your Genes to address vital role of genetic technology in modern medical practice at Boston's 2nd Annual Consumer Genetics Conference.

LOS ANGELES, CA, May 25, 2010 /24-7PressRelease/ -- With consumer genetics becoming more of a reality, Brandon Colby, MD, author of Outsmart Your Genes and founder and CEO of Existence Genetics, the world's first predictive medicine company, will join preeminent thinkers from government, healthcare, and biotechnology in leading discussion at the 2nd Annual Consumer Genetics Conference.

The unbiased forum that convenes in Boston at the Hynes Convention Center, June 2-4, will provide open dialogue from multiple perspectives on the challenges of and potential for genetic testing and personalized medicine. The scientific, clinical, business, and financial aspects of genetic testing will be candidly discussed by speakers and expert panels.

Dr. Colby will speak on the ease and importance of using predictive genetic testing in medical practices and illustrate the revolutionary work of Existence Genetics. In addition, he will offer his opinion on the current controversy over whether companies should be allowed to sell direct-to-consumer (DTC) and over-the-counter (OTC) genetic tests. The media are invited to attend this conference where they can hear Dr. Colby speak and meet with him one-on-one.

Founded in 2005 by a team of physicians, Existence Genetics grants health care professionals access to revolutionary predictive medicine services and delivers understandable, useful, and personalized solutions to protect and preserve health. The company's patent-pending Nexus technologies, including a proprietary, highly advanced gene chip known as the Nexus Gene Chip, enable comprehensive genetic testing and analysis that focuses on the personalized prevention of disease. This first-of-its-kind, highly accurate gene chip allows cost-effective, time-efficient screening for hundreds of potential disease predispositions, as well as for genes that are involved in the prevention and treatment of disease, thereby enabling the advent of genetically tailored prevention.

Through Existence's cutting-edge technological advancements, prediction and prevention of a wide range of both common and rare diseases are possible before they ever manifest. The future of medicine starts today.

To learn more about Existence Genetics and the Nexus technologies, visit www.existencegenetics.com.

Press Release Contact Information:

Robin Paul
Krupa Consulting
Account Executive
1352 North Harper
Los Angeles, CA
USA 90046
Voice: 323.448.0466
Website: Visit Our Website